Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT04504864
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT04504864
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04504864. Randomized; double masking; primary purpose treatment. Start 2020-10-01 (actual); primary completion 2022-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds
- Acronym
- AIM
- Condition
- Ischemic Stroke
- Intervention (Drug)
- low-dose aspirin
- Intervention (Drug)
- conventional-does aspirin
- Lead sponsor
- Xijing Hospital
- Collaborator
- Shaanxi Provincial People's Hospital
- Collaborator
- The First Affiliated Hospital of Jiaotong University
- Collaborator
- Tang-Du Hospital
- Collaborator
- First Affiliated Hospital Xi'an Jiaotong University
- Collaborator
- Xi'an Central Hospital
- Collaborator
- Xiangyang Central Hospital
- Collaborator
- Baoji Central Hospital
Record details
- Record id
cardio:ct-nct04504864- Content hash
1ff81c2edcd7fc2b31a694b03ebb7fed1c99ceeb70632fc44e122400db41a37b